Verma, Subodh http://orcid.org/0000-0002-4018-8533
Mudaliar, Sunder http://orcid.org/0000-0002-1133-7771
Greasley, Peter J. http://orcid.org/0000-0002-2529-4477
Funding for this research was provided by:
AstraZeneca Global
Article History
Received: 20 April 2023
Accepted: 17 August 2023
First Online: 9 November 2023
Declaration
:
: Subodh Verma holds a Tier 1 Canada Research Chair in Cardiovascular Surgery; and reports receiving research grants and/or speaking honoraria from Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, EOCI Pharmacomm Ltd, HLS Therapeutics, Janssen, Novartis, Novo Nordisk, Pfizer, PhaseBio, Sanofi, Sun Pharmaceuticals, and the Toronto Knowledge Translation Working Group. He is the President of the Canadian Medical and Surgical Knowledge Translation Research Group, a federally incorporated not-for-profit physician organization. Sunder Mudaliar has received speaker fees from AstraZeneca, has acted as a consultant for Bayer and has received research support from NIH/National Institute of Diabetes and Digestive and Kidney Diseases. Peter J. Greasley is an employee and shareholder of AstraZeneca.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.